The blood pressure lowering effects of glucagon-like peptide-1 receptor agonists: A mini-review of the potential mechanisms.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- The blood pressure lowering effects of glucagon-like peptide-1 receptor agonists: A mini-review of the potential mechanisms.
- Published In:
- Current opinion in pharmacology, 69, 102355 (2023)
- Database ID:
- RPEP-07317
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-07317APA
Ribeiro-Silva, Joao Carlos; Tavares, Caio A M; Girardi, Adriana C C. (2023). The blood pressure lowering effects of glucagon-like peptide-1 receptor agonists: A mini-review of the potential mechanisms.. Current opinion in pharmacology, 69, 102355. https://doi.org/10.1016/j.coph.2023.102355
MLA
Ribeiro-Silva, Joao Carlos, et al. "The blood pressure lowering effects of glucagon-like peptide-1 receptor agonists: A mini-review of the potential mechanisms.." Current opinion in pharmacology, 2023. https://doi.org/10.1016/j.coph.2023.102355
RethinkPeptides
RethinkPeptides Research Database. "The blood pressure lowering effects of glucagon-like peptide..." RPEP-07317. Retrieved from https://rethinkpeptides.com/research/ribeiro-silva-2023-the-blood-pressure-lowering
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.